81411-68-9 Usage
General Description
3-Bromo-1H-pyrazolo[3,4-b]pyrazine is a chemical compound classified under the heterocyclic compounds and more specifically under the family of Pyrazolo[3,4-b]pyrazines. These are organic compounds featuring pyrazolo[3,4-b]pyrazine moiety, a heterocycle formed by the fusion of a pyrazole ring with a pyrazine ring at positions 3 and 4. As an organic compound, this means that this substance contains carbon atoms. However, specific scientific data regarding its risk assessment, commercial and industrial applications, biological activities, toxicity, physical properties such as melting point, boiling point, density etc, are not readily available. It is important that proper handling, storage, and protective measures be observed while working with such chemical substances.
Check Digit Verification of cas no
The CAS Registry Mumber 81411-68-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,4,1 and 1 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 81411-68:
(7*8)+(6*1)+(5*4)+(4*1)+(3*1)+(2*6)+(1*8)=109
109 % 10 = 9
So 81411-68-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H3BrN4/c6-4-3-5(10-9-4)8-2-1-7-3/h1-2H,(H,8,9,10)
81411-68-9Relevant articles and documents
Neighbouring Group Participation in Formation of Condensed Azines. Formation of Pyrazolo(3,4-b)pyrazines, Isoxazolo(4,5-b)pyrazines and Isothiazolo(5,4-b)pyridine (Heterocycles, CCX)
Kocevar, Marjan,Vercek, Bojan,Stanovnik, Branko,Tisler, Miha
, p. 731 - 744 (2007/10/02)
Pyrazine- and pyridinecarboxamidoximes with an amino, potentially tautomeric hydroxy or mercapto group in ortho position could be transformed in the appropriate condensed azines.In this manner, representatives of pyrazolo(3,4-b)pyrazine, isoxazolo(4,5-b)pyrazine and isothiazolo(5,4-b)pyridine ring system were synthesized and some transformations investigated. - Keywords: Cyclization with N-N, N-O or N-S bond formation; Heterocyclic compounds